WallachBeth announced the completion of a Registered Direct Offering for Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery …
Capital Markets
WallachBeth Capital Announces Completion of $5.7 Million Joint Underwritten Public Offering for Lixte Biotechnology Holdings, Inc.
WallachBeth Capital announced the completion of a joint underwritten public offering of 1,200,000 shares for Lixte Biotechnology Holdings, Inc. (NASDAQ: …
WallachBeth Capital Announces Completion of the $5 Million IPO for Guardion Health Services
WallachBeth Capital, a leading provider of capital markets and institutional execution services, announced the closing of the initial public offering of …